Chronic intestinal pseudo-obstruction - Review and update 2008;Chronische intestinale pseudoobstruktion - Übersicht und update 2008

Zeitschrift fur Gastroenterologie

Volumn 46, Issue 7, 2008, Pages 704-711

  Seidl, Holger ^a   Pehl, C ^b   Schepp, W ^a   Schmidt, T ^a  

^a Chirurgische Klinik Munchen Bogenhausen   (Germany)

^b Krankenhaus Vilsbiburg

Author keywords

Manometry; Motility; Pseudoobstruction; Small bowel

Indexed keywords

CIPROFLOXACIN; CISAPRIDE; DOMPERIDONE; DOXYCYCLINE; ERYTHROMYCIN; IMMUNOSUPPRESSIVE AGENT; METOCLOPRAMIDE; METRONIDAZOLE; OCTREOTIDE; RIFAXIMIN; STEROID;

ABDOMINAL RADIOGRAPHY; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; EMERGENCY SURGERY; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL TRACT FUNCTION; HISTOPATHOLOGY; HUMAN; INTESTINE PSEUDOOBSTRUCTION; INTESTINE RADIOGRAPHY; INTESTINE TRANSPLANTATION; LABORATORY DIAGNOSIS; LABORATORY TEST; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT MONITORING; PROGNOSIS; REVIEW; TOTAL PARENTERAL NUTRITION; ABDOMINAL SURGERY; CHRONIC DISEASE; PARENTERAL NUTRITION;

CHRONIC DISEASE; DIGESTIVE SYSTEM SURGICAL PROCEDURES; HUMANS; INTESTINAL PSEUDO-OBSTRUCTION; PARENTERAL NUTRITION;

EID: 50149121974     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1027153     Document Type: Review

References (61)

1. Dudley HA, Sinclair IS, Mc Laren IF et al. Intestinal pseudo-obstruction. J R Coll Surg Edinb 1958; 3: 206-217
2. Stanghellini V, Corinaldesi R, Barbara L. Pseudo-obstruction syndromes. Baillieres Clin Gastroenterol 1988; 2: 225-254
3. Stanghellini V, Cogliandro RF, de Giorgio R et al. Chronic intestinal pseudo-obstruction: manifestations, natural history and management. Neurogastroenterol Motil 2007; 19: 440-452
4. De Giorgio R, Sarnelli G, Corinaldesi R et al. Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction. Gut 2004; 53: 1549-1552
5. Vantrappen G, Janssens J, Hellemans J et al. The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest 1977; 59: 1158-1166
6. Goyal RK, Hirano I. The enteric nervous system. N Engl J Med 1996; 334: 1106-1115
7. Wood J. Neural and humoral regulation of gastrointestinal motility. In: Schuster MM, Crowell MD, Koch KL (eds). Gastrointestinal mobility in health and disease. London: BC Decker, 2002: 19-42
8. Giaroni C, De Ponti F, Cosentino M et al. Plasticity in the enteric nervous system. Gastroenterology 1999; 117: 1438-1458
9. Boeckxstaens GE, Rumessen JJ, de Wit L et al. Abnormal distribution of the interstitial cells of cajal in an adult patient with pseudo-obstruction and megaduodenum. Am J Gastroenterol 2002; 97: 2120-2126
10. Vanderwinden JM, Liu H, De Laet MH et al. Study of the interstitial cells of Cajal in infantile hypertrophic pyloric stenosis. Gastroenterology 1996; 111: 279-288
11. Pardi DS, Miller SM, Miller DL et al. Paraneoplastic dysmotility: loss of interstitial cells of Cajal. Am J Gastroenterol 2002; 97: 1828-1833
12. Kenny SE, Vanderwinden JM, Rintala RJ et al. Delayed maturation of the interstitial cells of Cajal: a new diagnosis for transient neonatal pseudoobstruction. Report of two cases. J Pediatr Surg 1998; 33: 94-98
13. Connor FL, Di Lorenzo C. Chronic intestinal pseudo-obstruction: assessment and management. Gastroenterology 2006; 130: S29-S36
14. Faure C, Goulet O, Ategbo S et al. Chronic intestinal pseudoobstruction syndrome: clinical analysis, outcome, and prognosis in 105 children. French-Speaking Group of Pediatric Gastroenterology. Dig Dis Sci 1999; 44: 953-959
15. Di Lorenzo C. Pseudo-obstruction: current approaches. Gastroenterology 1999; 116: 980-987
16. Schappi MG, Smith VV, Milla PJ et al. Eosinophilic myenteric ganglionitis is associated with functional intestinal obstruction. Gut 2003; 52: 752-755
17. Tornblom H, Lang B, Clover L et al. Autoantibodies in patients with gut motility disorders and enteric neuropathy. Scand J Gastroenterol 2007; 42: 1289-1293
18. Jean WC, Dalmau J, Ho A et al. Analysis of the IgG subclass distribution and inflammatory infiltrates in patients with anti-Hu-associated paraneoplastic encephalomyelitis. Neurology 1994; 44: 140-147
19. Altermatt HJ, Rodriguez M, Scheithauer BW et al. Paraneoplastic anti-Purkinje and type I anti-neuronal nuclear autoantibodies bind selectively to central, peripheral, and autonomic nervous system cells. Lab Invest 1991; 65: 412-420
20. De Giorgio R, Guerrini S, Barbara G et al. Inflammatory neuropathies of the enteric nervous system. Gastroenterology 2004; 126: 1872-1883
21. Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med 2003; 349: 1543-1554
22. Lennon VA, Sas DF, Busk MF et al. Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. Gastroenterology 1991; 100: 137-142
23. Sodhi N, Camilleri M, Camoriano JK et al. Autonomic function and motility in intestinal pseudoobstruction caused by paraneoplastic syndrome. Dig Dis Sci 1989; 34: 1937-1942
24. Howe S, Eaker EY, Sallustio JE et al. Antimyenteric neuronal antibodies in scleroderma. J Clin Invest 1994; 94: 761-770
25. Sonsino E, Mouy R, Foucaud P et al. Intestinal pseudoobstruction related to cytomegalovirus infection of myenteric plexus. N Engl J Med 1984; 311: 196-197
26. Meneghelli UG. Chagas' disease: a model of denervation in the study of digestive tract motility. Braz J Med Biol Res 1985; 18: 255-264
27. Debinski HS, Kamm MA, Talbot IC et al. DNA viruses in the pathogenesis of sporadic chronic idiopathic intestinal pseudo-obstruction. Gut 1997; 41: 100-106
28. Basilisco G, Gebbia C, Peracchi M et al. Cerebellar degeneration and hearing loss in a patient with idiopathic myenteric ganglionitis. Eur J Gastroenterol Hepatol 2005; 17: 449-452
29. De Giorgio R, Bassotti G, Stanghellini V et al. Clinical, morpho-functional and immunological features of idiopathic myenteric ganglionitis. Gastroenterology 1996; 110: A655
30. Collins SM. The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology 1996; 111: 1683-1699
31. Camilleri M, Phillips SF. Acute and chronic intestinal pseudo-obstruction. Adv Intern Med 1991; 36: 287-306
32. De Giorgio R, Stanghellini V, Barbara G et al. Primary enteric neuropathies underlying gastrointestinal motor dysfunction. Scand J Gastroenterol 2000; 35: 114-122
33. Tornblom H, Lindberg G, Nyberg B et al. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology 2002; 123: 1972-1979
34. Stanghellini V, Cogliandro RF, De Giorgio R et al. Natural history of chronic idiopathic intestinal pseudo-obstruction in adults: a single center study. Clin Gastroenterol Hepatol 2005; 3: 449-458
35. Cogliandro R, Stanghellini V, Cogliandro L et al. Small bowel motility and natural history of chronic intestinal pseudo-obstruction. Gastroenterology 1998; 114: A735
36. Keller J, Layer P. Chronic intestinal pseudo-obstruction: pathogenesis, diagnosis and therapy. Z Gastroenterol 2002; 40: 85-95
37. Stanghellini V, Camilleri M, Malagelada JR. Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings. Gut 1987; 28: 5-12
38. Camilleri M. Jejunal manometry in distal subacute mechanical obstruction: significance of prolonged simultaneous contractions. Gut 1989; 30: 468-475
39. Hyman PE, Di Lorenzo C, McAdams L et al. Predicting the clinical response to cisapride in children with chronic intestinal pseudo-obstruction. Am J Gastroenterol 1993; 88: 832-836
40. Watanabe Y, Ho T, Ando H et al. Manometric evaluation of gastrointes-tinal motility in children with chronic intestinal pseudo-obstruction syndrome. J Pediatr Surg 1996; 31: 233-238
41. Di Lorenzo C, Flores AF, Buie T et al. Intestinal motility and jejunal feeding in children with chronic intestinal pseudo-obstruction. Gastroenterology 1995; 108: 1379-1385
42. Valdovinos MA, Camilleri M, Thomforde GM et al. Reduced accuracy of 14C-D-xylose breath test for detecting bacterial overgrowth in gastrointestinal motility disorders. Scand J Gastroenterol 1993; 28: 963-968
43. Ghirardo S, Sauter B, Levy G et al. Primary intestinal autoimmune disease as a cause of chronic intestinal pseudo-obstruction. Gut 2005; 54: 1206-1207
44. De Giorgio R, Camilleri M. Human enteric neuropathies: morphology and molecular pathology. Neurogastroenterol Motil 2004; 16: 515-531
45. Oton E, Moreira V, Redondo C et al. Chronic intestinal pseudo-obstruction due to lymphocytic leiomyositis: is there a place for immunomodulatory therapy? Gut 2005; 54: 1343-1344
46. Schuffler MD, Baird HW, Fleming CR et al. Intestinal pseudo-obstruction as the presenting manifestation of small-cell carcinoma of the lung. A paraneoplastic neuropathy of the gastrointestinal tract. Ann Intern Med 1983; 98: 129-134
47. Schobinger-Clement S, Gerber HA, Stallmach T. Autoaggressive inflammation of the myenteric plexus resulting in intestinal pseudoobstruction. Am J Surg Pathol 1999; 23: 602-606
48. De Giorgio R, Barbara G, Stanghellini V et al. Idiopathic myenteric ganglionitis underlying intractable vomiting in a young adult. Eur J Gastroenterol Hepatol 2000; 12: 613-616
49. Smith VV, Gregson N, Foggensteiner L et al. Acquired intestinal aganglionosis and circulating autoantibodies without neoplasia or other neural involvement. Gastroenterology 1997; 112: 1366-1371
50. Lipton AB, Knauer CM. Pseudo-obstruction of the bowel. Therapeutic trial of metoclopramide. Am J Dig Dis 1977; 22: 263-265
51. Camilleri M, Balm RK, Zinsmeister AR. Symptomatic improvement with one-year cisapride treatment in neuropathic chronic intestinal dysmotility. Aliment Pharmacol Ther 1996; 10: 403-409
52. Chami T, Schuster M, Crowell M et al. Effect of low dose erythromycin aon gastrointestinal motility and symptoms in chronic intestinal pseudoobstruction (abstract). Gastroenterology 1991; 100: 41
53. Soudah HC, Hasler WL, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med 1991; 325: 1461-1467
54. Trevisani GT, Hyman NH, Church JM. Neostigmine: safe and effective treatment for acute colonic pseudo-obstruction. Dis Colon Rectum 2000; 43: 599-603
55. Calvet X, Martinez JM, Martinez M. Repeated neostigmine dosage as palliative treatment for chronic colonic pseudo-obstruction in a patient with autonomic paraneoplastic neuropathy. Am J Gastroenterol 2003; 98: 708-709
56. Coulie B, Camilleri M. Intestinal pseudo-obstruction. Annu Rev Med 1999; 50: 37-55
57. Thompson AR, Pearson T, Ellul J et al. Percutaneous endoscopic colostomy in patients with chronic intestinal pseudo-obstruction. Gastrointest Endosc 2004; 59: 113-115
58. Bond GJ, Reyes JD. Intestinal transplantation for total/near-total aganglionosis and intestinal pseudo-obstruction. Semin Pediatr Surg 2004; 13: 286-292
59. Masetti M, Di Benedetto F, Cautero N et al. Intestinal transplantation for chronic intestinal pseudo-obstruction in adult patients. Am J Transplant 2004; 4: 826-829
60. Fell JM, Smith VV, Milla PJ. Infantile chronic idiopathic intestinal pseudo-obstruction: the role of small intestinal manometry as a diagnostic tool and prognostic indicator. Gut 1996; 39: 306-311
61. Lin Z, Chen JD. Advances in gastrointestinal electrical stimulation. Crit Rev Biomed Eng 2002; 30: 419-457